|
|||||
|
|
Demographic and clinical profiles of type 2 diabetes mellitus patients initiating sitagliptin in the real-world setting |
|
| Authors: | Manjiri Pawaskar Jinan Liu Swapnil Rajpathak Kristy Iglay Samuel S. Engel Hakima Hannachi |
| Affiliation: | 1. Merck &2. Co. Inc., Kenilworth, NJ, USA |
| Abstract: | |
| Keywords: | Clinical characteristics demographics sitagliptin Type 2 diabetes |